Suppr超能文献

用于优化心脏再同步治疗的替代起搏策略。

Alternative pacing strategies for optimal cardiac resynchronization therapy.

作者信息

Hua Juan, Kong Qiling, Chen Qi

机构信息

Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Front Cardiovasc Med. 2022 Sep 27;9:923394. doi: 10.3389/fcvm.2022.923394. eCollection 2022.

Abstract

Cardiac resynchronization therapy (CRT) biventricular pacing (BVP) improves morbidity, mortality, and quality of life, especially in subsets of patients with impaired cardiac function and wide QRS. However, the rate of unsuccessful or complicated left ventricular (LV) lead placement through coronary sinus is 5-7%, and the rate of "CRT non-response" is approximately 30%. These reasons have pushed physicians and engineers to collaborate to overcome the challenges of LV lead implantation. Thus, various alternatives to BVP have been proposed to improve CRT effectiveness. His bundle pacing (HBP) has been increasingly used by activating the His-Purkinje system but is constrained by challenging implantation, low success rates, high and often unstable thresholds, and low perception. Therefore, the concept of pacing a specialized conduction system distal to the His bundle to bypass the block region was proposed. Multiple clinical studies have demonstrated that left bundle branch area pacing (LBBAP) has comparable electrical resynchronization with HBP but is superior in terms of simpler operation, higher success rates, lower and stable capture thresholds, and higher perception. Despite their well-demonstrated effectiveness, the transvenous lead-related complications remain major limitations. Recently, leadless LV pacing has been developed and demonstrated effective for these challenging patient cohorts. This article focuses on the current state and latest progress in HBP, LBBAP, and leadless LV pacing as alternatives for failed or non-responsive conventional CRT as well as their limits and prospects.

摘要

心脏再同步治疗(CRT)双心室起搏(BVP)可改善发病率、死亡率和生活质量,尤其是在心脏功能受损且QRS波增宽的患者亚组中。然而,经冠状窦进行左心室(LV)导线植入失败或出现并发症的发生率为5%-7%,“CRT无反应”的发生率约为30%。这些原因促使医生和工程师合作以克服LV导线植入的挑战。因此,已提出各种替代BVP的方法以提高CRT的有效性。希氏束起搏(HBP)通过激活希氏-浦肯野系统越来越多地被使用,但受到植入难度大、成功率低、阈值高且常不稳定以及感知度低的限制。因此,提出了在希氏束远端起搏一个专门传导系统以绕过阻滞区域的概念。多项临床研究表明,左束支区域起搏(LBBAP)与HBP具有相当的电再同步作用,但在操作更简单、成功率更高、捕获阈值更低且稳定以及感知度更高方面更具优势。尽管它们的有效性已得到充分证明,但经静脉导线相关并发症仍然是主要限制因素。最近,无导线LV起搏已被开发出来,并已证明对这些具有挑战性的患者群体有效。本文重点介绍HBP、LBBAP和无导线LV起搏作为传统CRT失败或无反应的替代方法的现状和最新进展,以及它们的局限性和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a1/9551024/5fd995cbea86/fcvm-09-923394-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验